Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Effects of Lung Recruitment on Cerebral Hemodynamics(LRCH)

18. november 2026 oppdatert av: Xingui Dai, First People's Hospital of Chenzhou

Effects of Lung Recruitment on Cerebral Hemodynamics: a Single-center, Prospective, Randomized-order, Three-period, Self-controlled Design Trial

Patients receiving invasive mechanical ventilation may develop alveolar derecruitment due to atelectasis, secretion retention, changes in body position, or acute respiratory distress syndrome. Lung recruitment maneuvers reopen partially collapsed alveoli by briefly increasing transpulmonary pressure, thereby improving lung volume and oxygenation; however, elevated airway pressure may also affect venous return, mean arterial pressure, and carbon dioxide elimination, and thus alter cerebral blood flow. Therefore, improved oxygenation does not necessarily indicate stable cerebral circulation.

At present, when selecting a lung recruitment modality in clinical practice, clinicians often rely on oxygenation response, respiratory mechanics, and operator experience, while dynamic observation of cerebral hemodynamics remains relatively insufficient. Recording only two time points before and after the maneuver may miss transient but clinically meaningful changes during pressurization, maintenance of high pressure, and recovery. Therefore, under controlled and safe conditions, it is necessary to use three commonly used clinical lung recruitment maneuvers as observational scenarios to describe cerebral hemodynamic changes during lung recruitment and to explore possible physiological factors in conjunction with cardiac output, systemic blood pressure, carbon dioxide, and respiratory mechanics. The findings are expected to provide a physiological basis for bedside cerebral perfusion monitoring and risk identification; however, short-term changes in Vm alone cannot prove that a particular maneuver is safer or improves long-term outcomes.

Studieoversikt

Status

Har ikke rekruttert ennå

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

40

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 80 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • (1)Age 18 years or older.
  • (2)Receiving invasive mechanical ventilation through an endotracheal tube or tracheostomy.
  • (3)A clinical indication for a lung recruitment maneuver, with an expectation that three bedside observation periods can be completed during hospitalization.
  • (4)An adequate temporal acoustic window for reproducible transcranial Doppler recordings and an adequate echocardiographic window for reproducible left ventricular outflow tract velocity-time integral measurements.
  • (5)Axillary temperature between 36.0°C and 37.3°C.
  • (6)Written informed consent provided by the participant or a legally authorized representative.

Exclusion Criteria:

  • (1)Current use of vasoactive medications.
  • (2)Known severe cardiac dysfunction or severe pulmonary hypertension.
  • (3)Undrained pneumothorax, marked airflow limitation, giant pulmonary bullae, or another condition associated with a high risk of barotrauma.
  • (4)Known markedly elevated intracranial pressure or escalating treatment for intracranial hypertension.
  • (5)Any other condition that, in the investigator's judgment, makes participation inappropriate.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Sequence 1: A-B-C

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Eksperimentell: Sequence 2: B-C-A

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Eksperimentell: Sequence 3: C-A-B

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Eksperimentell: Sequence 1: A-C-B

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Eksperimentell: Sequence 1: B-A-C

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Eksperimentell: Sequence 1: C-B-A

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
mean flow velocity in the middle cerebral artery
Tidsramme: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Middle cerebral artery mean flow velocity (Vm, cm/s) will be measured using transcranial Doppler ultrasonography (TCD). In each study period, measurements will be obtained after at least 10 minutes of stable baseline ventilation. For method A, measurements will be obtained during the final 10 seconds of each 60-second PEEP step and 60 seconds after return to the original ventilation settings. For method B, measurements will be obtained at 35-40 seconds of sustained inflation and 40 seconds after return to the original settings. For method C, measurements will be obtained at baseline and 60 seconds after return to the original settings following the 120-second maneuver. No intra-maneuver TCD measurement is scheduled for method C.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Systolic blood flow velocity (Vs) of the middle cerebral artery
Tidsramme: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The Systolic blood flow velocity (Vs) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
diastolic blood flow velocity (Vd) of the middle cerebral artery
Tidsramme: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The diastolic blood flow velocity (Vd) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
pulsatility index (PI) of the middle cerebral artery
Tidsramme: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The pulsatility index (PI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
resistance index(RI) of the middle cerebral artery
Tidsramme: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The resistance index(RI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
Arterial partial pressure of carbon dioxide (PaCO2)
Tidsramme: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

PaCO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial partial pressure of oxygen (PaO2)
Tidsramme: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

PaO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial blood pH
Tidsramme: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

Arterial blood pH will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial blood lactate concentration
Tidsramme: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

Arterial blood lactate concentration (mmol/L) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Left ventricular outflow tract velocity-time integral (LVOT-VTI)
Tidsramme: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

LVOT-VTI (cm) will be measured by Doppler echocardiography at the same prespecified time points as transcranial Doppler measurements in each study period. The measured value and its change from the period-specific pre-maneuver baseline will be reported. For method C, measurements are scheduled only at baseline and during recovery, not during the 120-second maneuver.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
End-tidal carbon dioxide (EtCO2)
Tidsramme: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

EtCO2 (mmHg) will be monitored by capnography. A valid end-expiratory value will be recorded at the same prespecified time points as the TCD and LVOT-VTI measurements in each study period. The measured value and change from the period-specific baseline will be reported. If no valid expiratory waveform is available at a time point, the value will be recorded as missing.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Studiestol: Xingui Dai PhD, PHD, Chen Zhou NO.1 People's Hospital

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. november 2026

Primær fullføring (Antatt)

1. april 2028

Studiet fullført (Antatt)

1. mai 2028

Datoer for studieregistrering

Først innsendt

6. november 2026

Først innsendt som oppfylte QC-kriteriene

18. november 2026

Først lagt ut (Faktiske)

20. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

20. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • LRCH-001

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

JA

IPD-delingstidsramme

Beginning 6 months after publication of the main study results and available for 3 years.

Tilgangskriterier for IPD-deling

Qualified researchers may submit a written request including research purpose, analysis plan, requested data elements, and data protection measures. Requests will be reviewed by the principal investigator and the institution.

IPD-deling Støtteinformasjonstype

  • STUDY_PROTOCOL

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .